The advanced diffusion-weighted imaging technique RSI, short for restriction-spectrum MRI, is able to detect variations in tumor grade with voxel-level precision—and so could aid in customizing treatment of prostate cancer patients whose disease is spreading faster in some tumor regions than others.  

The FDA has approved a kit used to prepare and inject a PET imaging agent that can ferret out rare somatostatin receptor-positive neuroendocrine tumors in adult and pediatric patients.

Overall rates of colorectal cancer have been dropping for years. That’s the good news. The bad news is that the disease is on the rise among young people.

A major new analysis has entered the lifestyle vs. luck fray via JAMA Oncology, its authors having concluded that changes in lifestyle can ward off most cancers and that primary prevention ought to remain a priority for cancer control.

After conducting a meta-analysis of 346 phase I clinical trials involving more than 13,000 cancer patients, researchers have found that outcomes are significantly better when treatment targets the molecular characteristics of the individual tumor than when older, anatomic site-based approaches are used. 

Stricken with a brain tumor while pregnant with her first child, pathologist Rhea Birusingh, MD, of Nemours Children’s Health System in Florida, is now alive, well, cancer-free—and happy to be watching her son grow as normal following a stay in the neonatal intensive care unit. 

When colorectal cancer comes back after initial surgical intervention, chances are it won’t be detected until troubling symptoms prompt the patient to make an unscheduled interval visit. 

Stanford biologists and engineers are working with gold nanoparticles to identify tumor margins practically down to the level of the individual cell.